Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector

被引:67
作者
Gonzalez-Fernandez, T. [1 ,2 ,3 ,4 ,9 ]
Sathy, B. N. [1 ,2 ,10 ,11 ]
Hobbs, C. [3 ,4 ,5 ,6 ]
Cunniffe, G. M. [1 ,2 ]
McCarthy, H. O. [7 ]
Dunne, N. J. [1 ,7 ,8 ]
Nicolosi, V. [3 ,4 ,5 ,6 ]
O'Brien, F. J. [1 ,3 ,4 ,9 ]
Kelly, D. J. [1 ,2 ,3 ,4 ,9 ]
机构
[1] Trinity Coll Dublin, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin, Ireland
[2] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin, Ireland
[3] Trinity Coll Dublin, Adv Mat & Bioengn Res Ctr, Dublin, Ireland
[4] Royal Coll Surgeons Ireland, Dublin, Ireland
[5] Trinity Coll Dublin, Sch Phys, Dublin, Ireland
[6] Trinity Coll Dublin, Ctr Res Adapt Nanostruct & Nanodevices, Dublin, Ireland
[7] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland
[8] Dublin City Univ, Sch Mech & Mfg Engn, Dublin, Ireland
[9] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin, Ireland
[10] Amrita Vishwa Vidyapeetham Univ, Amrita Inst Med Sci, Amrita Ctr Nanosci & Mol Med, Kochi, India
[11] Amrita Vishwa Vidyapeetham Univ, Res Ctr, Kochi, India
基金
欧洲研究理事会; 爱尔兰科学基金会;
关键词
Non-viral gene delivery; Nanoparticle-based gene delivery vectors; MSC differentiation; MSC transfection; TISSUE ENGINEERING APPLICATIONS; COLLAGEN-BASED SCAFFOLDS; IN-VIVO; VIRAL VECTORS; CHONDROGENIC DIFFERENTIATION; CYTOSKELETAL ORGANIZATION; ENDOCHONDRAL OSSIFICATION; INTRACELLULAR DELIVERY; PENETRATING PEPTIDES; ACTIVATED MATRICES;
D O I
10.1016/j.actbio.2017.03.044
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Controlling the phenotype of mesenchymal stem cells (MSCs) through the delivery of regulatory genes is a promising strategy in tissue engineering (TE). Essential to effective gene delivery is the choice of gene carrier. Non-viral delivery vectors have been extensively used in TE, however their intrinsic effects on MSC differentiation remain poorly understood. The objective of this study was to investigate the influence of three different classes of non-viral gene delivery vectors: (1) cationic polymers (polyethylenimine, PEI), (2) inorganic nanoparticles (nanohydroxyapatite, nHA) and (3) amphipathic peptides (RALA peptide) on modulating stem cell fate after reporter and therapeutic gene delivery. Despite facilitating similar reporter gene transfection efficiencies, these nanoparticle-based vectors had dramatically different effects on MSC viability, cytoskeletal morphology and differentiation. After reporter gene delivery (pGFP or pLUC), the nHA and RALA vectors supported an elongated MSC morphology, actin stress fibre formation and the development of mature focal adhesions, while cells appeared rounded and less tense following PEI transfection. These changes in MSC morphology correlated with enhanced osteogenesis following nHA and RALA transfection and adipogenesis following PEI transfection. When therapeutic genes encoding for transforming growth factor beta 3 (TGF-beta 3) and/or bone morphogenic protein 2 (BMP2) were delivered to MSCs, nHA promoted osteogenesis in 2D culture and the development of an endochondral phenotype in 3D culture, while RALA was less osteogenic and appeared to promote a more stable hyaline cartilage-like phenotype. In contrast, PEI failed to induce robust osteogenesis or chondrogenesis of MSCs, despite effective therapeutic protein production. Taken together, these results demonstrate that the differentiation of MSCs through the application of non-viral gene delivery strategies depends not only on the gene delivered, but also on the gene carrier itself. Statement of Significance Nanoparticle-based non-viral gene delivery vectors have been extensively used in regenerative medicine, however their intrinsic effects on mesenchymal stem cell (MSC) differentiation remain poorly understood. This paper demonstrates that different classes of commonly used non-viral vectors are not inert and they have a strong effect on cell morphology, stress fiber formation and gene transcription in MSCs, which in turn modulates their capacity to differentiate towards osteogenic, adipogenic and chondrogenic lineages. These results also point to the need for careful and tissue-specific selection of nanoparticle-based delivery vectors to prevent undesired phenotypic changes and off-target effects when delivering therapeutic genes to damaged or diseased tissues. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:226 / 238
页数:13
相关论文
共 81 条
[1]   Nanoparticulate Alternatives for Drug Delivery [J].
Adair, James H. ;
Parette, Mylisa P. ;
Altinoglu, Erhan I. ;
Kester, Mark .
ACS NANO, 2010, 4 (09) :4967-4970
[2]  
Akhtar S, 2006, GENE THER, V13, P739, DOI 10.1038/sj.gt.3302692
[3]   Control of chondrogenesis by the transcription factor Sox9 [J].
Akiyama, Haruhiko .
MODERN RHEUMATOLOGY, 2008, 18 (03) :213-219
[4]   Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery [J].
Baker, A ;
Saltik, M ;
Lehrmann, H ;
Killisch, I ;
Mautner, V ;
Lamm, G ;
Christofori, G ;
Cotten, M .
GENE THERAPY, 1997, 4 (08) :773-782
[5]   Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions [J].
Ballarin-Gonzalez, Borja ;
Howard, Kenneth Alan .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (15) :1717-1729
[6]   Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors [J].
Baum, C ;
Kustikova, O ;
Modlich, U ;
Li, ZX ;
Fehse, B .
HUMAN GENE THERAPY, 2006, 17 (03) :253-263
[7]   Immune responses to gene therapy vectors: influence on vector function and effector mechanisms [J].
Bessis, N ;
GarciaCozar, FJ ;
Boissier, MC .
GENE THERAPY, 2004, 11 (Suppl 1) :S10-S17
[8]   Localized, direct plasmid gene delivery in vivo:: prolonged therapy results in reproducible tissue regeneration [J].
Bonadio, J ;
Smiley, E ;
Patil, P ;
Goldstein, S .
NATURE MEDICINE, 1999, 5 (07) :753-759
[9]   Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review [J].
Bose, Susmita ;
Tarafder, Solaiman .
ACTA BIOMATERIALIA, 2012, 8 (04) :1401-1421
[10]   Viral vectors: from virology to transgene expression [J].
Bouard, D. ;
Alazard-Dany, N. ;
Cosset, F-L .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (02) :153-165